INCYTE CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
INCYTE CORPORATION (INCY) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 7.49 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-04-28
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-31 was 7.49M shares, a 66.93% increase year-over-year.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-30 was 5.76M shares, a 79.46% increase year-over-year.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-30 was 4.75M shares.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-03-31 was 4.49M shares, a 63.99% increase year-over-year.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2025 was 5.50M shares, a 60.70% increase from fiscal 2024.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 3.42M shares, a 48.70% increase from fiscal 2023.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 2.30M shares, a 17.71% increase from fiscal 2022.
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 1.95M shares, a 18.71% increase from fiscal 2021.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|---|---|
| 2026-03-31 | 7.49M shares 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | 5.50M shares 10-K · filed 2026-02-10 | |||
| 2025-09-30 | 5.76M shares 10-Q · filed 2025-10-28 | 4.95M shares 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | 4.75M shares 10-Q · filed 2025-07-29 | 4.67M shares 10-Q · filed 2025-07-29 | ||
| 2025-03-31 | 4.49M shares 10-Q · filed 2026-04-28 | |||
| 2024-12-31 | 3.42M shares 10-K · filed 2026-02-10 | |||
| 2024-09-30 | 3.21M shares 10-Q · filed 2025-10-28 | 0.00 shares 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-07-29 | 0.00 shares 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | 2.73M shares 10-Q · filed 2025-04-29 | |||
| 2023-12-31 | 2.30M shares 10-K · filed 2026-02-10 | |||
| 2023-09-30 | 2.09M shares 10-Q · filed 2024-10-29 | 2.33M shares 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | 2.40M shares 10-Q · filed 2024-07-30 | 2.44M shares 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | 2.63M shares 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | 1.95M shares 10-K · filed 2025-02-10 | |||
| 2022-09-30 | 1.76M shares 10-Q · filed 2023-10-31 | 1.82M shares 10-Q · filed 2023-10-31 | ||
| 2022-06-30 | 2.00M shares 10-Q · filed 2023-08-01 | 1.78M shares 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | 1.62M shares 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | 1.65M shares 10-K · filed 2024-02-13 | |||
| 2021-09-30 | 1.40M shares 10-Q · filed 2022-11-01 | 1.87M shares 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | 2.17M shares 10-Q · filed 2022-08-02 | 2.12M shares 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | 2.07M shares 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | 0.00 shares 10-K · filed 2023-02-07 | |||
| 2020-06-30 | 2.88M shares 10-Q · filed 2021-08-03 | |||
| 2019-12-31 | 2.74M shares 10-K · filed 2022-02-08 | |||
| 2019-09-30 | 2.59M shares 10-Q · filed 2020-11-05 | 2.77M shares 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 2.86M shares 10-Q · filed 2020-08-04 | 2.93M shares 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | 3.00M shares 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | 3.25M shares 10-K · filed 2021-02-09 | |||
| 2018-09-30 | 3.34M shares 10-Q · filed 2019-10-29 | 3.34M shares 10-Q · filed 2019-10-29 | ||
| 2018-06-30 | 2.89M shares 10-Q · filed 2019-07-30 | 3.35M shares 10-Q · filed 2019-07-30 | ||
| 2017-09-30 | 5.81M shares 10-Q · filed 2018-10-30 | |||
| 2016-12-31 | 6.25M shares 10-K · filed 2019-02-14 | |||
| 2016-09-30 | 6.24M shares 10-Q · filed 2017-10-31 | 6.12M shares 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | 5.33M shares 10-Q · filed 2017-08-01 | 5.39M shares 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | 5.44M shares 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | 7.70M shares 10-K · filed 2018-02-15 | |||
| 2015-06-30 | 7.82M shares 10-Q · filed 2016-08-09 | |||
| 2014-09-30 | 10.04M shares 10-Q · filed 2015-11-03 | |||
| 2012-06-30 | 8.74M shares 10-Q · filed 2013-08-01 | |||
| 2010-06-30 | 6.66M shares 10-Q · filed 2011-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |